Invention Grant
- Patent Title: Crystalline pharmaceutical and methods of preparation and use thereof
-
Application No.: US15144892Application Date: 2016-05-03
-
Publication No.: US09890141B2Publication Date: 2018-02-13
- Inventor: John Burnier
- Applicant: SARcode Bioscience Inc.
- Applicant Address: US CA Brisbane
- Assignee: SARCODE BIOSCIENCE INC.
- Current Assignee: SARCODE BIOSCIENCE INC.
- Current Assignee Address: US CA Brisbane
- Agency: Troutman Sanders LLP
- Main IPC: C07D405/06
- IPC: C07D405/06 ; C07D405/10
Abstract:
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.
Public/Granted literature
- US20170029410A1 CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF Public/Granted day:2017-02-02
Information query
